BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17523586)

  • 1. Client outcomes from rural substance abuse treatment.
    Hiller ML; Leukefeld CG; Garrity TF; Godlaski T; Schoeneberger M; Townsend M; Hascal K
    J Psychoactive Drugs; 2007 Mar; 39(1):59-68. PubMed ID: 17523586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.
    McNeese-Smith D; Nyamathi A; Longshore D; Wickman M; Robertson S; Obert J; McCann M; Wells K; Wenzel SL
    Am J Drug Alcohol Abuse; 2007; 33(3):439-46. PubMed ID: 17613971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment services: funding and admissions.
    Butynski W
    NIDA Res Monogr; 1991; 106():20-52. PubMed ID: 1656262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional impact of treatment for substance abuse.
    Hoffmann NG; Harrison PA; Belille CA
    Adv Alcohol Subst Abuse; 1984; 3(3):83-94. PubMed ID: 6496235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
    McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
    Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse treatment with rural adolescents: issues and outcomes.
    Hall JA; Smith DC; Easton SD; An H; Williams JK; Godley SH; Jang M
    J Psychoactive Drugs; 2008 Mar; 40(1):109-20. PubMed ID: 18472670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care.
    Stein B; Orlando M; Sturm R
    Psychiatr Serv; 2000 Feb; 51(2):195-8. PubMed ID: 10655002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organization and financing of alcohol and substance abuse programs for American Indians and Alaska Natives.
    McFarland BH; Gabriel RM; Bigelow DA; Walker RD
    Am J Public Health; 2006 Aug; 96(8):1469-77. PubMed ID: 16809606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Employment and work among drug court clients: 12-month outcomes.
    Leukefeld C; Webster JM; Staton-Tindall M; Duvall J
    Subst Use Misuse; 2007; 42(7):1109-26. PubMed ID: 17668328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment illegal activities of a nationwide sample of adolescent substance abuse clients.
    Kinlock TW; Gordon MS; Battjes RJ
    J Psychoactive Drugs; 2004 Mar; 36(1):5-12. PubMed ID: 15152705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of addiction treatment services by Irish youth: does place of residence matter?
    Murphy KD; Byrne S; Sahm LJ; Lambert S; McCarthy S
    Rural Remote Health; 2014; 14(3):2735. PubMed ID: 25096268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

  • 17. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Documenting changes in the delivery of substance abuse services: the Status of the "100 best treatment centers for alcoholism and drug abuse" of 1988.
    Macmaster SA; Holleran LK; Chantus D; Kostyk L
    J Health Soc Policy; 2005; 20(3):67-77. PubMed ID: 16236679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.